Gene editing

Home » Emerging technologies » Gene editing

EdiGENE Raises $15 million in Series B Funding

Tokyo Japan and Cambridge, Mass. –April 10th, 2019–EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, announced todaythat it has raised 1.6 Billion-yen...